Nuclear Medicine Market by Type (Diagnostic, Therapeutic), Application (Oncology, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans), Procedural Volume Assessment (Diagnostic, Therapeutic), and by Region - Forecast to 2029

The global nuclear medicine market is estimated to be USD 4,519.2 million in 2021 and is expected to witness a CAGR of 8.71% during the forecast period. Growing incidence of rare diseases, increasing alpha radioimmunotherapy-based targeted cancer treatment, and rising government initiatives to increase availability of mo-99 are the key drivers driving the global market growth. However, small half-life of radiopharmaceuticals, and hospital budget cuts coupled with high equipment prices are the factors hindering the market growth.

Global Nuclear Medicine Market Size (USD Million), 2021-2029

Source: Erevna Healthcare

By Type

Based on type, the market is segmented into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further divided into alpha emitters, beta emitters, and brachytherapy isotopes. Technological advancements and investment by government in nuclear medicine is driving the global market.

By Application

On the basis of application, the market is segmented into diagnostic and therapeutic applications market. In 2021, the diagnostic segment accounted for the largest market share in the global nuclear medicine market. The diagnostic segment is further segmented into thyroid applications, cardiology, bone scans, pulmonary scans, and others. The thyroid applications segment is anticipated to grow with the fastest CAGR during the forecast period. This is attributed to the increasing chronic disease cases and prevalence of thyroid disorders.

By Procedural Volume Assessment

Based on procedural volume assessment, the market is segmented into diagnostic and therapeutic procedures. In 2021, the diagnostic procedures accounted for the largest share in the global market. This attributed to the broad application of diagnostic radioisotopes as compared to therapeutic radioisotopes. This segment is anticipated to grow at a lucrative CAGR during the forecast period owing to increasing research and development activities.

Regional Insights

North America dominated the nuclear medicine global market in 2021 and is projected to maintain its domination during the forecast period.  The reason for this market share is the increase in development of new technologies for radioisotope production, government funding, and company initiatives in the region that is expected to reinforce market growth in the future. The Asia Pacific is estimated to grow at the fastest growth rate during the forecast period increasing senior population and awareness about nuclear medicines & molecular imaging are contributing to the growth of the market in this region in this region

Competitor Insights

Some of the major companies in the market are Cardinal Health (U.S.), GE Healthcare (U.S.), Curium (France), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), JSC Isotope (Russia), and NorthStar Medical Radioisotopes (U.S.). Investment in R&D, strategic collaborations, mergers & acquisitions are some of the major strategies adopted by the leading players operating in the industry.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The nuclear medicine market report is categorized into the following segments and subsegments:

Nuclear Medicine Market, By Type (Revenue, 2021-2029, USD Million)

  • Diagnostic Nuclear Medicine
    • SPECT Radiopharmaceuticals
      • TC-99m
      • I-123
      • Tl-201
      • GA-67
      • Other SPECT Isotopes
    • PET Radiopharmaceuticals
      • F-18
      • Rb-82
      • Other PET Isotopes
  • Therapeutic Nuclear Medicine
    • Alpha Emitters
      • RA-223
    • Beta Emitters
      • Iodine-131
      • Y-90
      • SM-153
      • LU-177
      • RE-186
      • Other Beta Emitters
    • Brachytherapy Isotopes
      • Iodine-125
      • Iridium-192
      • Palladium-103
      • Cesium-131
      • Other Brachytherapy Isotopes

Nuclear Medicine Market, By Application (Revenue, 2021-2029, USD Million)

  • Diagnostic Applications
    • SPECT Applications
      • Cardiology
      • Bone Scans
      • Thyroid Applications
      • Pulmonary Scans
      • Other SPECT Applications
    • PET Applications
      • Oncology
      • Cardiology
      • Neurology
    • Other PET Applications
  • Therapeutic Applications
    • Thyroid Indications
    • Bone Metastasis
    • Endocrine Tumors
    • Lymphoma
    • Other Indications

Nuclear Medicine Market, By Procedural Volume Assessment (Revenue, 2021-2029, USD Million)

  • Diagnostic Procedures
    • SPECT Procedures
    • PET Procedures
  • Therapeutic Procedures
    • Beta Emitter Procedures
    • Alpha Emitter Procedures
    • Brachytherapy Procedures

Nuclear Medicine Market, By Region (Revenue, 2021-2029, USD Million)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Nuclear Medicine Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 15 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Nuclear Medicine Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Nuclear Medicine
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4

 

  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Nuclear Medicine Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Type
    1. Diagnostic Nuclear Medicine
      1. Diagnostic Nuclear Medicine Market Forecast, 2021-2029 (USD Million)
    2. Therapeutic Nuclear Medicine
      1. Therapeutic Nuclear Medicine Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Diagnostic Applications
      1. Diagnostic Applications Market Forecast, 2021-2029 (USD Million)
    2. Therapeutic Applications
      1. Therapeutic Applications Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Procedural Volume Assessment
    1. Diagnostic Procedures
      1. Diagnostic Procedures Market Forecast, 2021-2029 (USD Million)
    2. Therapeutic Procedures
      1. Therapeutic Procedures Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Nuclear Medicine Market
    1. North America Nuclear Medicine Market
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
      2. S. Nuclear Medicine Market
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
        2. Canada Nuclear Medicine Market
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
  1. Europe Nuclear Medicine Market
    1. Europe Nuclear Medicine Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
      2. Germany Nuclear Medicine Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
        2. UK Nuclear Medicine Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
          2. France Nuclear Medicine Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
            2. Spain Nuclear Medicine Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
              2. Italy Nuclear Medicine Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
                2. Rest of Europe Nuclear Medicine Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
  1. Asia Pacific Nuclear Medicine Market
    1. Asia Pacific Nuclear Medicine Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
      2. Japan Nuclear Medicine Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
        2. China Nuclear Medicine Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
          2. India Nuclear Medicine Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
            2. South Korea Nuclear Medicine Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
              2. Australia Nuclear Medicine Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Nuclear Medicine Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
  1. Latin America Nuclear Medicine Market
    1. Latin America Nuclear Medicine Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
      2. Brazil Nuclear Medicine Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
        2. Mexico Nuclear Medicine Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
          2. Argentina Nuclear Medicine Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
            2. Rest of Latin America Nuclear Medicine Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
  1. MEA Nuclear Medicine Market
    1. MEA Nuclear Medicine Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
      2. GCC Nuclear Medicine Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
        2. South Africa Nuclear Medicine Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
          2. Rest of MEA Nuclear Medicine Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast byProcedural Volume Assessment, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2021 & 2029
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Cardinal Health (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    2. GE Healthcare (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    3. Curium (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    4. Lantheus Medical Imaging (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    5. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    6. Bracco Imaging (Italy)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    7. Eczacýbaþý-Monrol Nuclear Products (Turkey)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    8. Nordion (Canada)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    9. Advanced Accelerator Applications (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    10. Nanolive SA (Switzerland)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Application Benchmarking
      5. Recent Developments
    11. NTP Radioisotopes (South Africa)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    12. JSC Isotope (Russia)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    13. NorthStar Medical Radioisotopes (U.S.)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Type Benchmarking
      5. Recent Developments
    16. Others Prominent Players

Conclusion & Recommendations

Select License Type

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports